tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DSKYF Stock Latest News

TROPION-Lung17: New Phase III Lung Cancer Trial Adds Medium-Term Upside Potential for AstraZeneca and Daiichi Sankyo
Company AnnouncementsTROPION-Lung17: New Phase III Lung Cancer Trial Adds Medium-Term Upside Potential for AstraZeneca and Daiichi Sankyo
3d ago
AZN
Daiichi Sankyo’s CLEAR Taiwan Study: A New Chapter in Lipid-Lowering Therapy
PremiumCompany Announcements
Daiichi Sankyo’s CLEAR Taiwan Study: A New Chapter in Lipid-Lowering Therapy
7d ago
DSKYF
3 Best Japanese Stocks to Invest In, According to AI Analyst
PremiumMarket News
3 Best Japanese Stocks to Invest In, According to AI Analyst
11d ago
GS
AZN
Daiichi Sankyo Wins Patent Dispute Appeal Against Seagen
PremiumCompany Announcements
Daiichi Sankyo Wins Patent Dispute Appeal Against Seagen
19d ago
DSKYF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
DSKYF Upcoming Earnings Report: What to Expect?
2M ago
Daiichi Sankyo’s Latest Clinical Trial: A Potential Game-Changer for Prostate Cancer Treatment
PremiumCompany AnnouncementsDaiichi Sankyo’s Latest Clinical Trial: A Potential Game-Changer for Prostate Cancer Treatment
2M ago
DSKYF
Daiichi Sankyo’s Promising Pediatric Cancer Study: A Potential Game-Changer
Premium
Company Announcements
Daiichi Sankyo’s Promising Pediatric Cancer Study: A Potential Game-Changer
2M ago
DSKYF
Daiichi Sankyo’s Promising Gastrointestinal Cancer Study: A Market Game-Changer?
Premium
Company Announcements
Daiichi Sankyo’s Promising Gastrointestinal Cancer Study: A Market Game-Changer?
2M ago
DSKYF
Daiichi Sankyo’s Latest Clinical Study: A Potential Game-Changer in Gastrointestinal Cancer Treatment
PremiumCompany Announcements
Daiichi Sankyo’s Latest Clinical Study: A Potential Game-Changer in Gastrointestinal Cancer Treatment
2M ago
DSKYF
Daiichi Sankyo’s Promising Breast Cancer Study: A Financial Perspective
PremiumCompany Announcements
Daiichi Sankyo’s Promising Breast Cancer Study: A Financial Perspective
2M ago
DSKYF
Daiichi Sankyo’s Promising Phase 2 Breast Cancer Study: A Potential Game-Changer
PremiumCompany Announcements
Daiichi Sankyo’s Promising Phase 2 Breast Cancer Study: A Potential Game-Changer
2M ago
DSKYF
Daiichi Sankyo’s Promising Study on Innovative Lung Cancer Treatments
PremiumCompany Announcements
Daiichi Sankyo’s Promising Study on Innovative Lung Cancer Treatments
2M ago
DSKYF
Daiichi Sankyo’s Promising Phase 3 Trial: A Potential Game-Changer in Gastric Cancer Treatment
PremiumCompany AnnouncementsDaiichi Sankyo’s Promising Phase 3 Trial: A Potential Game-Changer in Gastric Cancer Treatment
2M ago
DSKYF
Daiichi Sankyo’s Quizartinib Trial: A New Hope for AML Treatment?
Premium
Company Announcements
Daiichi Sankyo’s Quizartinib Trial: A New Hope for AML Treatment?
2M ago
DSKYF
Daiichi Sankyo’s Promising Lung Cancer Study: Key Updates and Market Impact
Premium
Company Announcements
Daiichi Sankyo’s Promising Lung Cancer Study: Key Updates and Market Impact
2M ago
DSKYF
Daiichi Sankyo’s Promising Study on Raludotatug Deruxtecan for Ovarian Cancer
PremiumCompany Announcements
Daiichi Sankyo’s Promising Study on Raludotatug Deruxtecan for Ovarian Cancer
2M ago
DSKYF
Daiichi Sankyo’s New Trial: A Potential Game-Changer for Hematological Malignancies
PremiumCompany Announcements
Daiichi Sankyo’s New Trial: A Potential Game-Changer for Hematological Malignancies
2M ago
DSKYF
Daiichi Sankyo’s Latest Clinical Study: A Potential Game-Changer in Esophageal Cancer Treatment
PremiumCompany Announcements
Daiichi Sankyo’s Latest Clinical Study: A Potential Game-Changer in Esophageal Cancer Treatment
2M ago
DSKYF
Daiichi Sankyo’s Promising Phase 3 Study on Prostate Cancer Treatment
PremiumCompany Announcements
Daiichi Sankyo’s Promising Phase 3 Study on Prostate Cancer Treatment
2M ago
DSKYF
Daiichi Sankyo’s Quizartinib Study: A Potential Game-Changer for Hepatic Impairment Treatment
PremiumCompany AnnouncementsDaiichi Sankyo’s Quizartinib Study: A Potential Game-Changer for Hepatic Impairment Treatment
2M ago
DSKYF
Daiichi Sankyo’s HER3-DXd Study: A Promising Step in Cancer Treatment
Premium
Company Announcements
Daiichi Sankyo’s HER3-DXd Study: A Promising Step in Cancer Treatment
2M ago
DSKYF
Daiichi Sankyo’s REJOICE-PanTumor01 Study: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Daiichi Sankyo’s REJOICE-PanTumor01 Study: A Potential Game-Changer in Cancer Treatment
2M ago
DSKYF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >